Current Pharmaceutical Biotechnology (CPB)

Current Pharmaceutical Biotechnology is an international, peer-reviewed scientific journal that serves as an essential forum for investigating and disseminating cutting-edge research at the interface of biotechnology and pharmaceutical sciences. Designed for researchers, clinicians, and industrial scientists, the journal highlights breakthroughs and emerging trends that shape drug discovery and therapeutic innovation. Each issue publishes high-quality original research articles, comprehensive and mini-reviews, and concise letters that reflect the latest scientific advancements. Its broad thematic scope includes areas such as biotechnology-driven drug design, molecular and cellular biology, DNA/protein engineering, synthetic biotechnology, and applications of nanotechnology for targeted drug delivery. The journal also embraces interdisciplinary contributions involving omics technologies, bioinformatics, applied microbiology, regenerative medicine, and molecular pharmacology, offering insights that deepen understanding and accelerate clinical translational potential. Moreover, it considers research advances in food chemistry with pharmaceutical implications, expanding its reach to nutrition-related bioactives and their therapeutic roles. With a bimonthly publication schedule, Current Pharmaceutical Biotechnology ensures timely dissemination of pivotal scientific work, helping professionals stay updated on innovations that could shape future medicines and improve patient outcomes. By facilitating critical dialogue across disciplines, it supports the global scientific community’s efforts to tackle complex challenges in modern pharmacotherapy and biotechnology.

Current Pharmaceutical Biotechnology (CPB) is :-

• International, Peer-Reviewed, Open Access, Refereed, Biotechnology in drug design and therapy, Pharmaceutical chemistry and molecular pharmaceutics, Biochemistry, molecular and cellular biology, proteomics, Nanobiotechnology and drug delivery systems, Regenerative medicine and molecular pharmacology , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1389-2010, E-ISSN: 1873-4316, Established: 2000, Impact Factor: 2.6
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE